Clinical Trial Update: Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

View source ↗

Summary

This clinical trial update reports completion of a study evaluating diffusion-weighted imaging MRI (DwI-MR) to predict chemotherapy response in patients with li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• DwI-MR

Snippet

Sponsor: Stefano Colagrande | Conditions: Liver Metastases, Hepatocarcinoma | Status: COMPLETED